FAITH - Factor XA Inhibitor-Related InTracranial Haemorrhage - FAITH

Study identifier:D9603R00022

ClinicalTrials.gov identifier:NCT06420011

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A Real-World, Observational, Multicentre Retrospective Analysis to Evaluate the Clinical Characteristics, Medical Management and Outcomes of Hospitalised Patients with Factor XA Inhibitor-Related InTracranial Haemorrhage (FAITH)

Medical condition

InTracranial Haemorrhage

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

350

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 08 Jul 2024
Estimated Primary Completion Date: 15 Jan 2025
Estimated Study Completion Date: 15 Jan 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria